In May, Dan reported that Mohr Davidow Ventures had sold its small stake in personal genomics company 23andMe — famous partly because of its co-founder, Anne Wojcicki, who’s married to Google co-founder Sergey Brin — and invested in rival Navigenics.

Both companies analyze your DNA and report if you are predisposed to certain genetic diseases.

Mohr Davidow’s Sue Siegel said today that although her firm’s parting with 23andMe was amicable, the two did not see eye-to-eye on what role venture capitalists should play. Mohr Davidow’s limited partners require the firm to take board seats with companies they invest in, she said, and 23andMe didn’t want venture capitalists on the board.

“We have a fiduciary duty to watch our investments, and when we commit we need to take board seats,” Siegel said. “I think that’s more of a norm than an exception.”

Three-year-old genetics startup 23andMe launched a surprisingly unscientific ad campaign this past weekend: it plastered its name across a giant white blimp that makes regular trips around the San Francisco Bay. I’m sure I’m not the only tech observer who — watching from a local beach — rubbed her eyes at the site of the giant [...]

Personalized genetics company 23andMe Inc. has secured $11 million of a $24.26 million venture round, according to a regulatory filing.

This is the company co-founded by Anne Wojcicki, wife of Google co-founder Sergey Brin, which had raised around $9 million in Series A funding from Google, Genentech, New Enterprise Associates and Mohr Davidow Ventures. Probably best described as one part personalized medicine, one part online informatics.

No investor info is disclosed on the filing, including if any new Google money would have come from Google.org or Google Ventures. The latter’s Rich Miner said Friday that all future Google venture investments would come from Google Ventures, but given

SAN FRANCISCO (AP) – For the price of a good men’s suit, a batch of new services will scan your genes and spot potential health risks, from cancer to lower back pain. It’s the business world’s answer to a deluge of new genetic discoveries pouring forth from scientists’ labs. Key investors in two of the [...]

23andMe, a genetics information startup founded by Anne Wojcicki and backed by Google, has raised $8.9 million according to a recent regulatory filing. It is unclear as to whether this financing is a second round or a continuation of the startup’s Series A raised in May. Google disclosed a $3.9 million investment in the company [...]

One downside of taking venture capital from a public company is that the deal can wind up in an 8-K filing. At that point, startups have two basic choices: Ignore the filing and hope nobody notices, or grudgingly emerge from stealth mode.  But there’s a big caveat: If your company was funded by Google, forget [...]